|
IPO11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.37478917139333E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.601790E-03 |
| Normal-vs-Stage3 |
1.980800E-03 |
| Normal-vs-Stage4 |
7.865700E-02 |
| Stage1-vs-Stage2 |
1.853210E-01 |
| Stage1-vs-Stage3 |
2.14099999999995E-05 |
| Stage1-vs-Stage4 |
4.17079999981418E-07 |
| Stage2-vs-Stage3 |
1.814790E-01 |
| Stage2-vs-Stage4 |
5.051800E-02 |
| Stage3-vs-Stage4 |
3.282000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.73181477439266E-12 |
| Normal-vs-AfricanAmerican |
8.879700E-03 |
| Normal-vs-Asian |
4.547000E-01 |
| Caucasian-vs-AfricanAmerican |
4.201200E-01 |
| Caucasian-vs-Asian |
5.568800E-01 |
| AfricanAmerican-vs-Asian |
8.195200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.81439982430243E-10 |
| Normal-vs-Female |
1.5529000307879E-09 |
| Male-vs-Female |
3.647400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.578000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.88080012569958E-10 |
| Normal-vs-Age(61-80Yrs) |
1.4908000389724E-09 |
| Normal-vs-Age(81-100Yrs) |
8.724200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.969000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.902400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.513200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.203000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.589400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.319200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.284400E-03 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
5.83229999999713E-05 |
| Normal-vs-Grade 4 |
8.416400E-01 |
| Grade 1-vs-Grade 2 |
9.963500E-02 |
| Grade 1-vs-Grade 3 |
1.823990E-02 |
| Grade 1-vs-Grade 4 |
3.721400E-03 |
| Grade 2-vs-Grade 3 |
1.00069999953156E-07 |
| Grade 2-vs-Grade 4 |
2.3973045770731E-11 |
| Grade 3-vs-Grade 4 |
5.717700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.658860E-03 |
| ccA subtype-vs-ccB subtype |
2.41640000231413E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.79669995442811E-09 |
| Normal-vs-N1 |
8.528800E-01 |
| N0-vs-N1 |
3.795600E-02 |
|
|
